Tekla Healthcare Investors (HQH) stock price

Tekla Healthcare Investors (HQH) is a Financial Services · Asset Management company listed on NYSE. Price $21.46 (-0.83%), Market cap $1.13B, P/E ratio 12.24, 52-week low–high $15.14 ~ $20.46.

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Tekla Healthcare Investors are updated in real time on BlackAll Trade.

Tekla Healthcare Investors financial summary

Key ratios · profitability · growth

Frequently asked questions

What is the current Tekla Healthcare Investors (HQH) stock price?

Tekla Healthcare Investors trades at $21.46 (-0.83%). Real-time quotes and charts are available on BlackAll Trade.

What is the Tekla Healthcare Investors (HQH) market cap?

Tekla Healthcare Investors has a market cap of about $1.13B. Its P/E ratio is 12.24.

What does Tekla Healthcare Investors (HQH) do?

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies